Summary
Induction of Epstein-Barr virus (EBV) capsid antigen synthesis in 59.6% of P3HR-1 cells was followed by a decrease to 70% in adenosine deaminase (ADA) activity. In Daudi cells synthesizing EBV early antigen, ADA activity did not decrease.
Similar content being viewed by others
References
Barton R, Martiniuk F, Hirschorn R, Goldschneider I: The distribution of adenosine deaminase among lymphocyte populations in the rat. J Immunol 122: 216–220, 1979
Carney WP, Rubin RH, Hoffman RA, Hensen WP, Heale K, Hirsch MS: Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol 126: 2114–2116, 1981
Carney WP, Iacoviello V, Hirsch MS: Functional properties of T lymphocytes and their subsets in cytomegalovirus mononucleosis. J Immunol 130: 390–393, 1983
Chang PK, Cantoni GL, Ray DA, Bader JP: Reduced levels of adenosine deaninase in chick embryo fibroblasts transformed by Rous sarcoma virus. Biochem Biophys Res Commun 78: 336–342, 1977
Crouch RB: The effects of influenza on host defense. J Infect Dis 144: 284–291, 1981
Filion LG, McGuire RL, Babiuk LA: Nonspecific suppressive effect of bovine herpesvirus type 1 on bovine leukocyte functions. Infect Immun 42: 106–112, 1983
Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ: Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2: 1067–1069, 1972
Giuste G: Adenosine deaminase. In: HU Bergmeyer (ed.) Methods of Enzymatic Analysis, 2nd Ed. Academic Press, 1974, pp 1092–1099
Hadar T, Rahima M, Kahan E, Didi J, Rakowsky E, Sarov B, Sarov I: Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients. J Med Virol 20: 329–339, 1986
Hinuma Y, Grace JT, Jr: Cloning of immunoglobulin producing human leukemic and lymphoma cells in long term cultures. Proc Soc Exp Biol Med (NY) 124: 107–111, 1977
Kim YP, Kahng JB, Chou JY, Ihm CW: Adenosine deaminase in human skin. J Dermatol 8: 493–497, 1981
Klien E, Klien G, Nadkarni JJ, Wigzell H, Clifford P: Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res 28: 1300–1310, 1981
Loh L, Hudson JB: Murine cytomegalovirus-induced immunosuppression. Infect Immun 36: 89–95, 1982
Long C, Derge JG, Hampar B: Procedure for Activating Epstein-Barr virus early antigen in non-producer cells by 5-iododeoxyuridine. J Nat Cancer Inst 52: 1355–1357, 1974
Luka J, Kallin B, Klein G: Induction of Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94: 228–231, 1979
Marks P, Rifkind RA: Erythroleukemic differentiation. Ann Rev Biochem 47: 419–448, 1978
Mangi RJ, Niederman JC, Kelleher JE, Dwyer JM, Evans AS, Cantor FS: Depression of cell mediated immunity during acute infectious mononucleosis. N Engl J Med 291: 1149–1153, 1974
Margalith M, Manor D, Cohen T: Cytotoxicity of arabinofuranosyladenine and erytro-9–2(hydroxy-3-nonyl) adenine to Epstein-Barr virus producer and non-producer lymphoma cells in culture. Cancer Biochem Biophys 6: 189–196, 1983
Margalith M: Adenosine deaminase activity in human lymphoma Daudi cells producers and nonproducers of herpes simplex type 1 virus. Annals New York Acad Sci 451: 321–323, 1984
Meuwissen HJ, Pollara B, Pickering RJ: Combined immunodeficiency disease associated with adenosine deaminase deficiency. J Pediatr 86: 169–181, 1975
Provisor AJ, Jacuone JJ, Chilcote RR, Neiburger RG, Crussi FC, Bacher R: Acquired aggamaglobulinemia after life threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children. N Engl J Med 293: 62–65, 1975
Reinherz EL, O'Brien C, Rosenthal P, Schlossman SF: The cellular basis for viral induced immunodeficiency: analysis by monoclonal antibodies. J Immunol 125: 1269–1274, 1980
Renouf JA, Wood A, Frazer IH, Thong YH, Chalmers AH: Depressed activities of purine enzymes in lymphocytes of patients infected with human immunodeficiency virus. Clin Chem 35: 1478–1481, 1989
Shipman C, Drach JC: Absence of adenosine deaminase activity in a mammalian cell line transformed by Rous sarcoma virus. Science 200: 1163–1165, 1978
Sullivan JL, Osborne WRA, Wedgwod RJ: Adenosine deaminase activity in lymphocytes. Br J Haematol 37: 157–158, 1977
Tung R, Silber R, Qagliata F, Conklyn M, Gottesman J, Hirschorn R: Adenosine deaminase activity in chronic lymphocytic leukemia. J Clin Invest 57: 756–761, 1976
Margalith M, Sarov B, Sarov I, Rinaldo C, Detels R, Phair J, Kaslow R, Ginsberg H, Saah A: Serum IgG and IgA antibodies specific to Epstein-Barr virus capsid antigen in a longitudinal study of human immunodeficiency virus infection and disease progression in homosexual men. AIDS Res Hum Retrovir 6: 607–616, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Margalith, M., Hendler, I. Adenosine deaminase activity in relation to the appearance of early and late Epstein-Barr virus antigens induced in lymphoblastoid cells. Mol Cell Biochem 108, 99–103 (1991). https://doi.org/10.1007/BF00233113
Issue Date:
DOI: https://doi.org/10.1007/BF00233113